Soares; Christopher J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Soares; Christopher J..The latest application filed is for "cgrp agonist peptides".
Company Profile
0.27.32
- Soares; Christopher J. - La Jolla CA US
- Soares; Christopher J - Cambridge CA
- Soares; Christopher J. - Wilmington DE
- Soares; Christopher J. - San Diego CA
- Soares; Christopher J. - Cambridge CA
- Soares; Christopher J - La Jola CA
Patent Activity
| Patent | Date |
|---|---|
| CGRP agonist peptides Grant 9,951,115 - Soares April 24, 2 | 2018-04-24 |
| Freight removal regulation apparatus Grant 9,721,485 - Soares August 1, 2 | 2017-08-01 |
| Engineered polypeptides having enhanced duration of action Grant 9,593,154 - Erickson , et al. March 14, 2 | 2017-03-14 |
| Hybrid polypeptides with selectable properties Grant 9,453,063 - Levy , et al. September 27, 2 | 2016-09-27 |
| Cgrp Agonist Peptides App 20160207975 - Soares; Christopher J. | 2016-07-21 |
| Peptide Antagonists Of The Calcitonin Cgrp Family Of Peptide Hormones And Their Use App 20160145315 - Soares; Christopher J. | 2016-05-26 |
| GLP-1 receptor agonist compounds having stabilized regions Grant 9,217,022 - Alfaro-Lopez , et al. December 22, 2 | 2015-12-22 |
| Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use Grant 9,193,776 - Soares November 24, 2 | 2015-11-24 |
| GIP analog and hybrid polypeptides with selectable properties Grant 9,133,260 - Levy , et al. September 15, 2 | 2015-09-15 |
| Freight Removal Regulation Apparatus App 20150208804 - Soares; Christopher J. | 2015-07-30 |
| Site-specific Enzymatic Modification Of Exendins And Analogs Thereof App 20150111246 - Samant; Manoj P. ; et al. | 2015-04-23 |
| Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20140371148 - GHOSH; Soumitra S. ; et al. | 2014-12-18 |
| GIP and exendin hybrid polypeptides Grant 8,895,498 - Levy , et al. November 25, 2 | 2014-11-25 |
| Peptide Antagonists Of The Calcitonin Cgrp Family Of Peptide Hormones And Their Use App 20140329752 - Soares; Christopher J. | 2014-11-06 |
| Hybrid Polypeptides With Selectable Properties App 20140249299 - Levy; Odile Esther ; et al. | 2014-09-04 |
| Peptide-peptidase inhibitor conjugates and methods of using same Grant 8,759,295 - Ghosh , et al. June 24, 2 | 2014-06-24 |
| Engineered Polypeptides Having Enhanced Duration Of Action App 20140107019 - ERICKSON; Mary ; et al. | 2014-04-17 |
| Hybrid polypeptides with selectable properties Grant 8,697,647 - Levy , et al. April 15, 2 | 2014-04-15 |
| Polypeptide Conjugate App 20140066370 - Forood; Behrouz Bruce ; et al. | 2014-03-06 |
| Peptide-peptidase-inhibitor conjugates and methods of making and using same Grant 8,598,314 - Ghosh , et al. December 3, 2 | 2013-12-03 |
| Methods for treatment using amylin family peptides Grant 8,598,120 - Soares , et al. December 3, 2 | 2013-12-03 |
| Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties App 20130281374 - Levy; Odile Esther ; et al. | 2013-10-24 |
| Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130196913 - Levy; Odile Esther ; et al. | 2013-08-01 |
| DPP-IV resistant GIP hybrid polypeptides with selectable properties Grant 8,497,240 - Levy , et al. July 30, 2 | 2013-07-30 |
| Glp-1 Receptor Agonist Compounds Having Stabilized Regions App 20130184203 - Alfaro-Lopez; Josue ; et al. | 2013-07-18 |
| Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130137631 - LEVY; Odile Esther ; et al. | 2013-05-30 |
| GIP analog and hybrid polypeptides with selectable properties Grant 8,404,637 - Levy , et al. March 26, 2 | 2013-03-26 |
| Hybrid Polypeptides With Selectable Properties App 20120253023 - LEVY; Odile Esther ; et al. | 2012-10-04 |
| GIP analog and hybrid polypeptides with selectable properties Grant 8,263,545 - Levy , et al. September 11, 2 | 2012-09-11 |
| Amylin Family Peptides And Methods For Making And Using Them App 20120196796 - Soares; Christopher J. ; et al. | 2012-08-02 |
| Amylin family peptides Grant 8,114,958 - Soares , et al. February 14, 2 | 2012-02-14 |
| Hybrid polypeptides having glucose lowering activity Grant 8,076,288 - Levy , et al. December 13, 2 | 2011-12-13 |
| DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties App 20110136737 - Levy; Odile Esther ; et al. | 2011-06-09 |
| Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same App 20100292172 - GHOSH; SOUMITRA S. ; et al. | 2010-11-18 |
| Peptide-peptidase-inhibitor Conjugates And Methods Of Making And Using Same App 20100286365 - Ghosh; Soumitra S. ; et al. | 2010-11-11 |
| Composition and Methods for Treatment of Congestive Heart Failure App 20100029554 - Ghosh; Soumitra S. ; et al. | 2010-02-04 |
| Hybrid Polypeptides with Selectable Properties App 20090286723 - Levy; Odile Esther ; et al. | 2009-11-19 |
| Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20090186817 - Ghosh; Soumitra S. ; et al. | 2009-07-23 |
| Gip Analog And Hybrid Polypeptides With Selectable Properties App 20090036364 - Levy; Odile Esther ; et al. | 2009-02-05 |
| Gip Analog And Hybrid Polypeptides With Selectable Properties App 20080312157 - Levy; Odile Esther ; et al. | 2008-12-18 |
| Amylin Family Peptides And Methods For Making And Using Them App 20080274952 - Soares; Christopher J ; et al. | 2008-11-06 |
| Hybrid polypeptides with selectable properties App 20060293232 - Levy; Odile Esther ; et al. | 2006-12-28 |
| Hybrid polypeptides with selectable properties App 20060094652 - Levy; Odile Esther ; et al. | 2006-05-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 